title: [Is it necessary to monitor blood hydroxychloroquine concentrations in patients with systemic lupus erythematosus?].
authors.affiliation: e-mail:nathalie costedoat@psl.aphp.fr(N.Costedoat-Chalumeau)
authors.forename: N
authors.initials: N
authors.lastname: Costedoat-Chalumeau
authors.forename: Z
authors.initials: Z
authors.lastname: Amoura
authors.forename: J S
authors.initials: JS
authors.lastname: Hulot
authors.forename: P
authors.initials: P
authors.lastname: Lechat
authors.forename: J C
authors.initials: JC
authors.lastname: Piette
mesh_terms: D002851:Chromatography, High Pressure Liquid; D004311:Double-Blind Method; D006801:Humans; D006886:Hydroxychloroquine / Q000008:administration & dosage / Q000097:blood* / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000188:drug therapy*; D010349:Patient Compliance; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors
chemical_list: D006886:Hydroxychloroquine